Fundamentals of molecular targeted therapy for primary central nervous system lymphoma based on genomic alterations
Not Applicable
Recruiting
- Conditions
- primary central nervous system lymphoma
- Registration Number
- JPRN-UMIN000003929
- Lead Sponsor
- Department of Neurosurgery, Faculty of Medicine, University of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
nothing particular
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identify primary CNS lymphoma specific genomic alterations. Among them, find molecular target for development and progression of lymphoma
- Secondary Outcome Measures
Name Time Method